CYTOTIL15
Live / Allowed — Notice of allowance issued (as of 16 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99143125
- Mark type
- Stylized text
- Filed
- 17 Apr 2025
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 001 — Chemicals: Cells for scientific, laboratory or medical research.
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer.
Owner
- Obsidian Therapeutics, Inc., Cambridge, MA, US
- Obsidian Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Sept 2025 — ASSIGNED TO EXAMINER
- 26 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Apr 2025 — NEW APPLICATION ENTERED